Sign Up for Future FDA Hearings

April 17th, 2012 by MorganDowney Leave a reply »

The safety and effectiveness of lorcaserin, developed by Arena Pharmaceuticals will be the subject of a meeting of the Endocrinologic and Metabolic Drug Advisory Committee on May 10, 2012. April 18, 2012 is the deadline for filing a request to present oral testimony. See http://www.fda.gov/AdvisoryCommittees/Calendar/ucm296516.htm

Medical Devices for the treatment of obesity will be the subject of two days of a meeting of the Gastroenterology and Urology Devices Panel on May 10 and 11, 2012.  The committee will discuss general issues regarding trial design for clinical studies on the safety and effectiveness of weight loss devices. The deadline for signing up for participating as a public witness is April

http://www.fda.gov/AdvisoryCommittees/Calendar/ucm297473.htm?utm_source=fdaSearch&utm_medium=website&utm_term=Gastroenterology%20advisory%20committee&utm_content=1


 

Leave a Reply

*